Suppr超能文献

[通过中耳离子导入法给予新诺地卡酮治疗耳鸣]

[Treatment of tinnitus by Neolidocatone administered by iontophoresis into the middle ear].

作者信息

Sejna I, Marik E

机构信息

Otolaryngologická klinika ILF, Praha.

出版信息

Cesk Otolaryngol. 1990 Aug;39(4):221-4.

PMID:2289244
Abstract

The authors describe a possible therapeutic approach mitigating tinnitus. It is not causal treatment but only symptomatic and extends the group of methods which influence tinnitus. The authors describe their own experience with iontophoresis of the middle ear with Neolidocatone-a derivate of Lidocaine which was done with a SANOMATIC apparatus, using galvanic current 1.5 mA. In one third of the patients it proved possible to mitigate the tinnitus permanently, in the remaining patients it persisted in the original intensity. The group of patients was heterogeneous from idiopathic tinnitus without impaired hearing, patients with otosclerosis, cervicocranial syndrome to those with Ménière's disease. The cause of tinnitus did not influence the therapeutic results.

摘要

作者描述了一种减轻耳鸣的可能治疗方法。这不是病因治疗,而只是对症治疗,并且扩展了影响耳鸣的方法类别。作者描述了他们使用SANOMATIC仪器,通过1.5毫安直流电进行中耳离子导入新利多卡托宁(利多卡因的衍生物)的自身经验。三分之一的患者耳鸣被证实可以永久减轻,其余患者耳鸣仍维持原来的强度。患者群体各异,包括无听力受损的特发性耳鸣患者、耳硬化症患者、颈颅综合征患者以及梅尼埃病患者。耳鸣的病因不影响治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验